0 Commentaires
0 Parts
858 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
- Connectez-vous pour aimer, partager et commenter!
- The Ticagrelor Market Growth Is Driven By Increasing Burden Of Cardiovascular DiseasesThe ticagrelor market covers the drug ticagrelor which is an oral, reversible, P2Y12 platelet aggregation inhibitor. Ticagrelor helps to prevent platelets from clumping together and forming clots. It is mainly used for reducing thrombotic cardiovascular events such as heart attack or stroke in patients with acute coronary syndrome or history of myocardial infarction. Ticagrelor market provides...0 Commentaires 0 Parts 356 Vue 0 Aperçu
- Ticagrelor Market Is Estimated To Witness High Growth Owing To Increasing Prevalence Of Coronary Artery DiseaseTicagrelor is an antiplatelet medication used to prevent blood clots and to treat conditions such as myocardial infarction and unstable angina. It has shown significantly better outcomes than clopidogrel and is usually preferred in patients who are undergoing percutaneous coronary intervention. Ticagrelor works by reversibly binding to the P2Y12 receptor on platelets and inhibiting adenosine...0 Commentaires 0 Parts 609 Vue 0 Aperçu
- Ticagrelor Market Is Estimated To Witness High Growth Owing To Rising Prevalence Of Coronary Artery DiseaseThe Ticagrelor Market is estimated to be valued at US$ 1285.83 Mn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Ticagrelor is an antiplatelet drug used to treat acute coronary syndromes, including heart attacks and unstable angina. It works by inhibiting platelet...0 Commentaires 0 Parts 694 Vue 0 Aperçu
- Ticagrelor: An Effective Antiplatelet DrugIntroduction Ticagrelor, sold under the brand name Brilinta, is an oral antiplatelet medication used to prevent blood clots and reduce the risk of heart attack or stroke in people with acute coronary syndrome or a history of myocardial infarction. Ticagrelor selectively and reversibly binds to the adenosine diphosphate (ADP) receptor P2Y12 on platelets, minimally inhibiting ADP-induced platelet...0 Commentaires 0 Parts 659 Vue 0 Aperçu
- Antiplatelet Drugs Play An Important Role In Preventing And Treating Cardiovascular DiseasesAntiplatelet Drugs: An overview Blood platelets play a crucial role in blood clotting and healing wounds. However, excess clotting of platelets inside blood vessels can lead to dangerous conditions like heart attacks and strokes. Antiplatelet drugs, also known as platelet aggregation inhibitors, help prevent excessive clotting by inhibiting the ability of platelets to adhere to each other and...0 Commentaires 0 Parts 544 Vue 0 Aperçu